Prevalence of acute intermittent porphyria in a Mexican psychiatric population
- PMID: 11068084
- DOI: 10.1016/s0188-4409(00)00092-8
Prevalence of acute intermittent porphyria in a Mexican psychiatric population
Abstract
Background: Acute intermittent porphyria is a hereditary error of porphyrin metabolism in which the main metabolic defect is caused by a decrease in porphobilinogen deaminase activity. Previous work has demonstrated a higher prevalence of acute intermittent porphyria in the psychiatric patient population than in the general population. The goal of this study was evaluate 300 psychiatric patients and 150 control subjects to detect acute intermittent porphyria by measurement of porphobilinogen (PBG) deaminase activity in blood.
Methods: Screening for porphobilinogen deaminase activity was carried out by fluorometric measurement of porphyrins synthesized during 1 h in blood and the measurement of delta-aminolevulinic acid and porphobilinogen in urine.
Results: We found two psychiatric patients, one male and one female, with decreased porphobilinogen deaminase activity. When the families of these patients were studied, one brother was found to have an abnormality. Among controls, a woman was found to have the abnormality and her father was found to have typical features of the disease.
Conclusions: These results indicate a prevalence of porphyria in Mexican psychiatric patients similar to controls, and that measurement of PBG deaminase activity is a good tool for defining acute intermittent porphyria carriers.
Similar articles
-
Heterogeneity of acute intermittent porphyria: a subtype with normal erythrocyte porphobilinogen deaminase activity in Germany.Eur J Clin Chem Clin Biochem. 1996 Aug;34(8):613-8. doi: 10.1515/cclm.1996.34.8.613. Eur J Clin Chem Clin Biochem. 1996. PMID: 8877336
-
Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.Clin Pharmacokinet. 2007;46(4):335-49. doi: 10.2165/00003088-200746040-00006. Clin Pharmacokinet. 2007. PMID: 17375984 Clinical Trial.
-
Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France.J Intern Med. 1997 Sep;242(3):213-7. doi: 10.1046/j.1365-2796.1997.00189.x. J Intern Med. 1997. PMID: 9350165
-
Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors.J Inherit Metab Dis. 2004;27(1):19-27. doi: 10.1023/B:BOLI.0000016613.75677.05. J Inherit Metab Dis. 2004. PMID: 14970743 Review.
-
[Acute intermittent porphyria in 2 Moroccan families. Clinical and biological study].Rev Med Interne. 1996;17(6):477-81. doi: 10.1016/0248-8663(96)86442-3. Rev Med Interne. 1996. PMID: 8758536 Review. French.
Cited by
-
Psychiatric Aspects of Acute Porphyria: a Comprehensive Review.Curr Psychiatry Rep. 2018 Feb 2;20(1):5. doi: 10.1007/s11920-018-0867-1. Curr Psychiatry Rep. 2018. PMID: 29392446 Review.
-
Anxiety and depression in the acute porphyrias.J Inherit Metab Dis. 2005;28(6):1099-107. doi: 10.1007/s10545-005-4561-1. J Inherit Metab Dis. 2005. PMID: 16435203
-
Acute Hepatic Porphyria.J Clin Transl Hepatol. 2015 Mar;3(1):17-26. doi: 10.14218/JCTH.2014.00039. Epub 2015 Mar 15. J Clin Transl Hepatol. 2015. PMID: 26357631 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical